A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men With Non-Metastatic (M0) Castration-Resistant Prostate Cancer

Name: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men With Non-Metastatic (M0) Castration-Resistant Prostate Cancer
Creator: Vivli
Published: 2024-05-14T19:58:29+08:00

DataCite Commons2025-06-01 更新2026-05-07 收录

前列腺癌药物试验

去势抵抗性前列腺癌

数据链接：

https://search.vivli.org/doiLanding/studies/PR00010102/isLanding 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate cancer.

提供机构：

Vivli

创建时间：

2024-05-14